After resigning as FDA commissioner in March, Scott Gottlieb now joins the pharmaceutical industry he once regulated. In other pharma news: details emerge about House Speaker Nancy Pelosi's drug pricing proposal; a few states explore importing drugs from outside the U.S.; the future of biologics; and more.

from Kaiser Health News https://ift.tt/2RIPiyr

Related Posts:

0 comments:

Post a Comment

Popular Posts